KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Emergent BioSolutions (EBS) Debt Ratio (2016 - 2025)

Historic Debt Ratio for Emergent BioSolutions (EBS) over the last 17 years, with Q3 2025 value amounting to 0.45.

  • Emergent BioSolutions' Debt Ratio rose 134.86% to 0.45 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.45, marking a year-over-year increase of 134.86%. This contributed to the annual value of 0.48 for FY2024, which is 9501.3% up from last year.
  • Per Emergent BioSolutions' latest filing, its Debt Ratio stood at 0.45 for Q3 2025, which was up 134.86% from 0.47 recorded in Q2 2025.
  • In the past 5 years, Emergent BioSolutions' Debt Ratio ranged from a high of 0.48 in Q4 2024 and a low of 0.14 during Q4 2022
  • Over the past 5 years, Emergent BioSolutions' median Debt Ratio value was 0.29 (recorded in 2021), while the average stood at 0.31.
  • In the last 5 years, Emergent BioSolutions' Debt Ratio tumbled by 4823.92% in 2022 and then soared by 9501.3% in 2024.
  • Quarter analysis of 5 years shows Emergent BioSolutions' Debt Ratio stood at 0.27 in 2021, then crashed by 48.24% to 0.14 in 2022, then surged by 72.89% to 0.24 in 2023, then soared by 95.01% to 0.48 in 2024, then decreased by 4.97% to 0.45 in 2025.
  • Its Debt Ratio was 0.45 in Q3 2025, compared to 0.47 in Q2 2025 and 0.47 in Q1 2025.